U.S. Insurance Stock News

If you are wondering whether ESAB at around US$102.92 is offering value or risk at this point, the recent mix of returns gives a useful starting point. Over the past week and month, the stock has returned 4.0% and 7.8% respectively, while year to date it is down 8.6%. The 1 year return shows a 13.9% decline, compared with an 80.7% gain over 3 years. Recent coverage has focused on ESAB's share price performance over different time frames and how that compares with the wider Machinery...

The United States market has remained flat over the past week but has experienced a significant 30% increase over the past year, with earnings projected to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for sustained revenue expansion and innovation in a dynamic economic environment.

The United States market has remained flat over the past week, yet it has experienced a notable 30% rise over the last year, with earnings projected to grow by 16% annually in the coming years. In this context, identifying stocks that are potentially undervalued can offer investors opportunities to acquire shares at a discount relative to their intrinsic value.

IDACORP, Inc. recently declared a common stock dividend of US$0.88 per share, payable on June 1, 2026, to shareholders of record as of May 5, 2026, while analysts highlight a history of earnings outperformance and a positive Earnings ESP ahead of the next quarterly report. This combination of ongoing cash returns to shareholders and analyst expectations of another potential earnings beat is drawing renewed attention to IDACORP’s earnings resilience and income profile. Next, we’ll examine how...

Vertex Pharmaceuticals received expanded FDA approval for ALYFTREK and TRIKAFTA, extending cystic fibrosis treatment to additional age groups and genetic variants. The decision broadens the eligible patient pool for two core therapies in Vertex's cystic fibrosis portfolio. This regulatory milestone is specific to Vertex Pharmaceuticals, ticker NasdaqGS:VRTX, and relates to its cystic fibrosis franchise. Vertex Pharmaceuticals, NasdaqGS:VRTX, now has broader FDA backing for ALYFTREK and...

Bank of Hawaii (BOH) has drawn fresh attention after recent share price moves, including a negative 1 day return and positive month and past 3 months performances, prompting investors to reassess the regional lender’s current valuation. See our latest analysis for Bank of Hawaii. At a share price of $77.87, Bank of Hawaii’s recent 6.06% 1 month and 9.99% 3 month share price returns sit alongside a 22.20% 1 year total shareholder return and a very large 3 year total shareholder return of...

Lam Research (LRCX) has put up another solid quarter, with Q3 2026 revenue at US$5.8b, basic EPS at US$1.46, and trailing twelve month EPS at US$5.32 as earnings over the last year grew 44.1%. The company has seen revenue move from US$4.7b in Q3 2025 to US$5.8b in Q3 2026, while quarterly basic EPS moved from US$1.04 to US$1.46 over the same period. This has set the stage for the 30.9% net margin reported over the last twelve months versus 27.2% in the prior year. Overall, these results point...

A federal judge has approved a US$425 million settlement involving Capital One Financial (COF), addressing allegations over interest paid on older 360 Savings accounts compared with its newer Performance Savings product and mandating equalized rates. See our latest analysis for Capital One Financial. The legal settlement lands as Capital One digests mixed first quarter results, higher credit loss provisions and recent acquisitions. The 1 month share price return of 6.49% contrasts with a...

In April 2026, NorthWestern Energy Group obtained Federal Energy Regulatory Commission acceptance of its revisions to depreciation rates in the Montana Open Access Transmission Tariff, effective January 1, 2026, with no protests or adverse comments filed. This approval clarifies the regulatory treatment of NorthWestern’s transmission asset depreciation, potentially improving visibility on cost recovery and long-term infrastructure planning. We’ll now examine how this clarified depreciation...

The United States market has been flat over the last week but is up 30% over the past year, with earnings forecast to grow by 16% annually. In this environment, growth companies with significant insider ownership can be appealing as they often demonstrate strong commitment from those who know the business best.

In the last week, the market has been flat, but over the past 12 months, it has risen by 30%, with earnings expected to grow by 16% annually in the coming years. In this context, identifying stocks with strong financial health is crucial for investors looking to capitalize on growth opportunities. Although the term "penny stocks" might seem outdated, these shares often represent smaller or newer companies that can offer significant value and growth potential when backed by solid fundamentals.

Analyst expectations ahead of March 2026 earnings National Fuel Gas (NFG) is back on investors’ radar as multiple research outlets highlight optimism around its March 2026 quarterly earnings, noting a pattern of regular consensus EPS beats and a currently positive Earnings ESP. See our latest analysis for National Fuel Gas. At a share price of $89.15, National Fuel Gas has seen a 9.16% 90 day share price return and a 17.17% 1 year total shareholder return, suggesting momentum has been...

Wondering if Core & Main at around US$48.95 is offering good value right now, or if the best part of the move is already behind it. The share price shows mixed recent returns, with a 7 day move of 5.8% decline, a 30 day return of 3.2% decline, year to date at 8.4% decline, but a 3 year gain of 87.8% that may still catch your eye. Recent coverage has focused on Core & Main's position in trade distribution and how investors are reassessing companies in this niche after shifts in market...

Earlier in 2025, Vulcan Materials reported solid safety and financial results for the first half of the year, with expanding margins and higher adjusted EBITDA despite challenging weather, and reaffirmed its full-year adjusted EBITDA guidance supported by improving public and private demand. The company highlighted accelerating bookings and growing backlogs tied to infrastructure spending, data center work, and a recovering private nonresidential sector, underlining the breadth of demand...

In the last week, the United States market has remained flat, yet it boasts an impressive 30% increase over the past year with earnings expected to grow by 16% annually. In such a dynamic environment, identifying stocks that have not yet caught widespread attention but show potential for growth can be key to finding valuable opportunities.

Wondering if Toast at around US$27.92 is a bargain or just fairly priced? This breakdown will help you size up what the current market price might be implying. The stock has had mixed returns, with a 2.0% decline over the last 7 days, a 4.9% gain over the last month, and year to date and 1 year returns of 17.9% and 22.3% declines, alongside a 52.8% gain over 3 years. Recent coverage has focused on Toast's role in restaurant payments and software, along with how investors are weighing its...

Earlier this week, Chubb Limited reported Q1 2026 results showing net income of US$2.32 billion versus US$1.33 billion a year earlier, with diluted EPS from continuing operations rising to US$5.88 from US$3.29. The quarter was marked by broad-based premium growth, stronger underwriting performance with an 84% combined ratio, and continued capital returns including US$1.14 billion of share repurchases that completed a US$3.47 billion buyback program. Against this backdrop of stronger earnings...

SEI Investments (SEIC) opened 2026 with Q1 revenue of US$622.2 million and basic EPS of US$1.43, set against trailing twelve month revenue of US$2.4 billion and EPS of US$6.01. Over recent quarters, revenue has moved from US$551.3 million in Q1 2025 to US$622.2 million in Q1 2026, while quarterly basic EPS has shifted from US$1.20 to US$1.43. This provides a clearer view of how profitability is tracking into the new year. With net profit margins in the data improving over the past year, this...

This article examines whether Autohome at around US$18.37 represents a bargain or a value trap by looking closely at what the numbers indicate about the stock. The share price has fluctuated recently, with a 6.3% gain over the past 30 days but a 1.8% decline over the last week, alongside a 19.0% fall year to date and a 29.6% decline over the past year. Recent headlines around Autohome have highlighted its position in the Chinese online auto platform space and how investors are weighing that...

Why Warner Bros. Discovery Stock Is Drawing Attention Now Warner Bros. Discovery (WBD) is back on investor radars after recent share price moves, with the stock showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Warner Bros. Discovery. At a share price of $26.90, Warner Bros. Discovery has seen modest short term share price pressure, with a 90 day share price return of a 5.88% decline, while the 1 year total shareholder return of 216.47% points to...

A federal judge has temporarily lifted restrictions on new solar and wind projects on federal land. This decision opens the door for additional project development opportunities across the renewable energy sector. Sunrun (NasdaqGS:RUN) could see an expanded addressable market as policy hurdles ease for new installations. Sunrun, trading at about $12.96, sits at the center of investor attention as policy risk shifts in the sector. The stock has seen an 83.8% gain over the past year, while...

Range Resources (NYSE:RRC) reported a record-setting first quarter of 2026, with operational and financial results ahead of prior levels. The company posted its highest-ever natural gas and NGL premiums, alongside robust free cash flow and lower debt. Range Resources authorized a new $1.5 billion share repurchase program, expanding its shareholder return plan. Range Resources enters this update with its shares at $42.64 and a strong multi-year track record, including a 20.8% gain year to...

TransMedics Group recently presented an update on its heart and lung transplant clinical programs and unveiled its new Controlled Hypothermic Organ Preservation System (CHOPS), an active cooling device for donor organ storage, at the 2026 International Society of Heart and Lung Transplantation meeting in Toronto. By positioning CHOPS as an FDA-regulated, stand-alone control device for key OCS ENHANCE Heart Part B and OCS DENOVO Lung trials, the company is seeking to tighten trial design and...

If you are wondering whether DaVita's current share price reflects its true worth, this breakdown will help you connect the recent moves in the stock with what the underlying valuation signals are saying. DaVita last closed at US$155.03, with returns of 4.7% over the past week, 1.1% over the past month, 35.4% year to date, 11.1% over 1 year, 76.2% over 3 years and 35.4% over 5 years. Recent coverage around DaVita has focused on how the stock fits within the broader healthcare space and how...